000566 海南海药
交易中 12-20 13:11:36
资讯
新帖
简况
海南海药(000566)12月10日股东户数7.8万户，较上期增加5.6%
证券之星 · 12-16
海南海药(000566)12月10日股东户数7.8万户，较上期增加5.6%
A股海南自贸区概念局部异动，海南瑞泽、海南发展双双涨停，丽尚国潮、海南海药、海南高速、华闻集团等跟涨。
美港电讯 · 12-11
A股海南自贸区概念局部异动，海南瑞泽、海南发展双双涨停，丽尚国潮、海南海药、海南高速、华闻集团等跟涨。
海南海药(000566)11月30日股东户数7.39万户，较上期减少1.17%
证券之星 · 12-09
海南海药(000566)11月30日股东户数7.39万户，较上期减少1.17%
海南海药(000566.SZ)与新西兰AFT就相关产品独家商业化权益达成合作
智通财经 · 12-06
海南海药(000566.SZ)与新西兰AFT就相关产品独家商业化权益达成合作
海南海药(000566.SZ)：注射用氨曲南通过仿制药质量和疗效一致性评价
智通财经 · 12-06
海南海药(000566.SZ)：注射用氨曲南通过仿制药质量和疗效一致性评价
海南海药最新公告：与AFT就相关产品独家商业化权益达成合作
证券之星 · 12-06
海南海药最新公告：与AFT就相关产品独家商业化权益达成合作
A股海南自贸区板块探底回升，海南椰岛触及涨停，海马汽车、海南华铁、海南发展、海南海药跟涨。
美港电讯 · 12-05
A股海南自贸区板块探底回升，海南椰岛触及涨停，海马汽车、海南华铁、海南发展、海南海药跟涨。
A股创新药板块震荡走高，前沿生物、海南海药此前涨停，百利天恒涨超9%，赛伦生物、康辰药业走高。
美港电讯 · 12-02
A股创新药板块震荡走高，前沿生物、海南海药此前涨停，百利天恒涨超9%，赛伦生物、康辰药业走高。
异动快报：海南海药（000566）12月2日9点32分触及涨停板
证券之星 · 12-02
异动快报：海南海药（000566）12月2日9点32分触及涨停板
A股海南自贸区板块高开，海南发展、欣龙控股、葫芦娃竞价涨停，康芝药业、海南海药、海南高速等高开。
美港电讯 · 12-02
A股海南自贸区板块高开，海南发展、欣龙控股、葫芦娃竞价涨停，康芝药业、海南海药、海南高速等高开。
海南海药(000566)11月20日股东户数7.48万户，较上期增加28.04%
证券之星 · 11-29
海南海药(000566)11月20日股东户数7.48万户，较上期增加28.04%
海南海药最新公告：与海口国科及西恩尤斯正式签署《初始合资合同》
证券之星 · 11-26
海南海药最新公告：与海口国科及西恩尤斯正式签署《初始合资合同》
海南海药因信息披露违规等违规行为被证监会责令改正
证券之星 · 11-13
海南海药因信息披露违规等违规行为被证监会责令改正
海南海药最新公告：收到海南证监局行政监管措施决定书
证券之星 · 11-12
海南海药最新公告：收到海南证监局行政监管措施决定书
异动快报：海南海药（000566）11月8日9点46分触及涨停板
证券之星 · 11-08
异动快报：海南海药（000566）11月8日9点46分触及涨停板
海南海药(000566.SZ)拟与西恩尤斯等就ECMO配套产品开展合作 加快布局高端医疗器械领域
智通财经 · 11-07
海南海药(000566.SZ)拟与西恩尤斯等就ECMO配套产品开展合作 加快布局高端医疗器械领域
海南海药最新公告：股票交易异常波动 近期经营情况正常
证券之星 · 11-07
海南海药最新公告：股票交易异常波动 近期经营情况正常
海南海药最新公告：与海口国科、西恩尤斯签订初始合资合同
证券之星 · 11-07
海南海药最新公告：与海口国科、西恩尤斯签订初始合资合同
海南海药：签署不超2亿元初始合资合同
美港电讯 · 11-07
海南海药：签署不超2亿元初始合资合同
11月7日海南海药涨停分析：食品，民营医院，保健品概念热股
证券之星 · 11-07
11月7日海南海药涨停分析：食品，民营医院，保健品概念热股
加载更多
公司概况
公司名称：
海南海药股份有限公司
所属行业：
医药制造业
上市日期：
1994-05-25
主营业务：
海南海药股份有限公司主营业务是药品及医疗器械研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列及其他产品。公司产品枫蓼肠胃康颗粒2023年市场占有率56%，国内排名第一，头孢唑肟钠2023年市场占有率10.6%，国内排名第二，头孢西丁钠2023年市场占有率15.9,%，国内排名第二。
发行价格：
5.80
{"stockData":{"symbol":"000566","market":"SZ","secType":"STK","nameCN":"海南海药","latestPrice":5.4,"timestamp":1734671496000,"preClose":5.32,"halted":0,"volume":20070300,"delay":0,"floatShares":1166000000,"shares":1297000000,"eps":-0.2907,"marketStatus":"交易中","marketStatusCode":2,"change":0.08,"latestTime":"12-20 13:11:36","open":5.36,"high":5.45,"low":5.3,"amount":108000000,"amplitude":0.0282,"askPrice":5.4,"askSize":1065,"bidPrice":5.39,"bidSize":492,"shortable":0,"etf":0,"ttmEps":-0.2907,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734678000000},"adr":0,"adjPreClose":5.32,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":5.85,"lowLimit":4.79,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1297365126,"pbRate":3.91,"roa":"--","roe":"--","epsLYR":-0.0821,"committee":0.076558,"marketValue":7006000000,"floatMarketCap":6296000000,"peRate":-18.575852,"changeRate":0.015,"turnoverRate":0.0172,"status":0},"requestUrl":"/m/hq/s/000566","defaultTab":"news","newsList":[{"id":"2491528566","title":"海南海药(000566)12月10日股东户数7.8万户，较上期增加5.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491528566","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491528566?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:02","pubTimestamp":1734339765,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海南海药披露，截至2024年12月10日公司股东户数为7.8万户，较11月30日增加4140.0户，增幅为5.6%。在化学制药行业个股中，海南海药股东户数高于行业平均水平，截至12月10日，化学制药行业平均股东户数为3.11万户。从股价来看，2024年11月30日至2024年12月10日，海南海药区间涨幅为1.77%，在此期间股东户数增加4140.0户，增幅为5.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600021870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0146","000566","BK0188","BK0239","BK0070"],"gpt_icon":0},{"id":"2490007940","title":"A股海南自贸区概念局部异动，海南瑞泽、海南发展双双涨停，丽尚国潮、海南海药、海南高速、华闻集团等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2490007940","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490007940?lang=zh_cn&edition=full","pubTime":"2024-12-11 13:14","pubTimestamp":1733894087,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0273","BK0257","BK0209","BK0098","600738","BK0010","BK0028","BK0077","BK0108","BK0000","159982","BK0132","BK0239","000793","000886","BK0040","002163","BK0012","BK0146","BK0188","BK0004","BK0019","BK0145","BK0070","BK0174","000566","BK0060","BK0086","BK0131","BK0235","BK0268","BK0022","002596","399300"],"gpt_icon":0},{"id":"2490223745","title":"海南海药(000566)11月30日股东户数7.39万户，较上期减少1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490223745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490223745?lang=zh_cn&edition=full","pubTime":"2024-12-09 17:02","pubTimestamp":1733734939,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海南海药披露，截至2024年11月30日公司股东户数为7.39万户，较11月20日减少872.0户，减幅为1.17%。在化学制药行业个股中，海南海药股东户数高于行业平均水平，截至11月30日，化学制药行业平均股东户数为3.1万户。从股价来看，2024年11月20日至2024年11月30日，海南海药区间涨幅为5.22%，在此期间股东户数减少872.0户，减幅为1.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900021824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0188","BK0146","BK0070","BK0060"],"gpt_icon":0},{"id":"2489283667","title":"海南海药(000566.SZ)与新西兰AFT就相关产品独家商业化权益达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2489283667","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489283667?lang=zh_cn&edition=full","pubTime":"2024-12-06 19:27","pubTimestamp":1733484438,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药 发布公告，公司全资子公司海南海药销售有限公司近日与AFT Pharmaceuticals Ltd.签署了《独家供应和分销协议》，双方主要就AFT的Lipo-Sachets脂质体维生素 C、Lipo-Sachets 脂质体维生素 D3、Ferro Lipo-Sachets补铁剂以及Kiwisoothe奇异舒咀嚼片四款产品在中国境内的商业化达成合作。AFT同意授予海药销售独家经销权，在合作区域内营销、销售和分销产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000566","BK0239","BK0188","AFT","BK0146","BK0070","BK0060"],"gpt_icon":0},{"id":"2489833232","title":"海南海药(000566.SZ)：注射用氨曲南通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2489833232","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489833232?lang=zh_cn&edition=full","pubTime":"2024-12-06 19:24","pubTimestamp":1733484258,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药(000566.SZ)发布公告，近日，公司全资子公司海口市制药厂有限公司(“海口市制药厂”)获得国家药品监督管理局核准签发的化学药品“注射用氨曲南”的《药品补充申请批准通知书》。据悉，氨曲南通过阻断肽聚糖交联来抑制细菌细胞壁的合成。主要用于治疗敏感革兰氏阴性菌所致的各种感染，包括下呼吸道感染、腹腔内感染、皮肤和皮肤结构感染、尿路感染(复杂和非复杂的)、妇科感染和败血症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0188","000566","BK0070","BK0146","BK0060"],"gpt_icon":0},{"id":"2489394283","title":"海南海药最新公告：与AFT就相关产品独家商业化权益达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2489394283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489394283?lang=zh_cn&edition=full","pubTime":"2024-12-06 19:10","pubTimestamp":1733483420,"startTime":"0","endTime":"0","summary":"海南海药公告，公司全资子公司海药销售近日与 AFT PharmaceuticalsLtd.（简称“AFT”）签署了《独家供应和分销协议》，双方主要就AFT的Lipo-Sachets®脂质体维生素C、Lipo-Sachets® 脂质体维生素D3、Ferro LipoSachets® 补铁剂以及 Kiwisoothe® 奇异舒咀嚼片四款产品在中国境内的商业化达成合作。AFT 同意授予海药销售独家经销权，在合作区域内（直接或通过其关联公司）营销、销售和分销产品。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600037034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","BK0070","BK0146","000566","BK0188"],"gpt_icon":0},{"id":"2489749951","title":"A股海南自贸区板块探底回升，海南椰岛触及涨停，海马汽车、海南华铁、海南发展、海南海药跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2489749951","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489749951?lang=zh_cn&edition=full","pubTime":"2024-12-05 10:05","pubTimestamp":1733364317,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603300","399300","BK0145","BK0146","BK0188","BK0065","000566","BK0203","BK0060","BK0070","BK0131","BK0040","000572","159982","002163","BK0257","BK0169","BK0239","BK0077","BK0264","BK0028","BK0199","600238","BK0113","BK0215","BK0010"],"gpt_icon":0},{"id":"2488649591","title":"A股创新药板块震荡走高，前沿生物、海南海药此前涨停，百利天恒涨超9%，赛伦生物、康辰药业走高。","url":"https://stock-news.laohu8.com/highlight/detail?id=2488649591","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488649591?lang=zh_cn&edition=full","pubTime":"2024-12-02 13:54","pubTimestamp":1733118886,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688221","688506","000566","159982","BK0146","BK0188","BK0070","BK0239","688163","603590","159992","BK0060","06978","399300","BK1161","BK1574"],"gpt_icon":0},{"id":"2488428619","title":"异动快报：海南海药（000566）12月2日9点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2488428619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488428619?lang=zh_cn&edition=full","pubTime":"2024-12-02 09:36","pubTimestamp":1733103410,"startTime":"0","endTime":"0","summary":"证券之星12月2日盘中消息，9点32分海南海药触及涨停板。目前价格6.2，上涨9.93%。该股为海南概念，海南自由贸易港，民营医院概念热股，当日海南概念概念上涨3.51%，海南自由贸易港概念上涨2.12%，民营医院概念上涨1.29%。近5日资金流向一览见下表：海南海药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200003055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0070","BK0239","BK0188"],"gpt_icon":0},{"id":"2488616733","title":"A股海南自贸区板块高开，海南发展、欣龙控股、葫芦娃竞价涨停，康芝药业、海南海药、海南高速等高开。","url":"https://stock-news.laohu8.com/highlight/detail?id=2488616733","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488616733?lang=zh_cn&edition=full","pubTime":"2024-12-02 09:29","pubTimestamp":1733102950,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0188","BK0040","BK0131","BK0070","BK0028","BK0060","399300","BK0247","BK0239","000566","BK0273","BK0042","002163","BK0048","BK0257","000955","BK0022","000886","159982","BK0145","605199","BK0010","300086","BK0146"],"gpt_icon":0},{"id":"2487380055","title":"海南海药(000566)11月20日股东户数7.48万户，较上期增加28.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487380055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487380055?lang=zh_cn&edition=full","pubTime":"2024-11-29 17:02","pubTimestamp":1732870929,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海南海药披露，截至2024年11月20日公司股东户数为7.48万户，较10月20日增加1.64万户，增幅为28.04%。在化学制药行业个股中，海南海药股东户数高于行业平均水平，截至11月20日，化学制药行业平均股东户数为3.11万户。从股价来看，2024年10月20日至2024年11月20日，海南海药区间涨幅为33.0%，在此期间股东户数增加1.64万户，增幅为28.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900025315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0146","000566","BK0188","BK0070","BK0239"],"gpt_icon":0},{"id":"2486029792","title":"海南海药最新公告：与海口国科及西恩尤斯正式签署《初始合资合同》","url":"https://stock-news.laohu8.com/highlight/detail?id=2486029792","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486029792?lang=zh_cn&edition=full","pubTime":"2024-11-26 17:30","pubTimestamp":1732613440,"startTime":"0","endTime":"0","summary":"海南海药公告，公司与海口国科及西恩尤斯已正式签署《初始合资合同》，三方将积极促进其他未确定事项的协商，努力推进合作项目顺利落地。该合同为初始合同，规定各方不晚于自签署日起的第九个月届满之日，完成合同内约定的成立条件，如未能在规定日期前满足、完成，初始合资合同可终止。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600031281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","000566","BK0146","BK0239","BK0070"],"gpt_icon":0},{"id":"2483703962","title":"海南海药因信息披露违规等违规行为被证监会责令改正","url":"https://stock-news.laohu8.com/highlight/detail?id=2483703962","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483703962?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:00","pubTimestamp":1731430845,"startTime":"0","endTime":"0","summary":"证券之星消息，11月13日海南海药公开信息显示，海南海药股份有限公司因信息披露违规,未依法履行其他职责被中国证券监督管理委员会海南监管局责令改正。三是公司关于个别高级管理人员职务任免信息的披露不准确,违反了《管理办法》第三条第一款的规定。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300000387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","000566","BK0060","BK0070","BK0239","BK0188"],"gpt_icon":0},{"id":"2482670376","title":"海南海药最新公告：收到海南证监局行政监管措施决定书","url":"https://stock-news.laohu8.com/highlight/detail?id=2482670376","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482670376?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:09","pubTimestamp":1731413357,"startTime":"0","endTime":"0","summary":"海南证监局决定对公司采取责令改正的行政监管措施。公司表示，本次行政监管措施不会影响正常的经营管理活动，将认真吸取教训，制定整改计划，落实整改措施，并及时报送书面整改报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200033955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0146","000566","BK0070","BK0239","BK0060"],"gpt_icon":0},{"id":"2481644731","title":"异动快报：海南海药（000566）11月8日9点46分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2481644731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481644731?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:51","pubTimestamp":1731030660,"startTime":"0","endTime":"0","summary":"证券之星11月8日盘中消息，9点46分海南海药触及涨停板。目前价格7.11，上涨10.06%。该股为医疗信息化，CAR-T疗法，央企改革概念热股，当日医疗信息化概念上涨1.14%，CAR-T疗法概念上涨1.13%，央企改革概念上涨0.73%。近5日资金流向一览见下表：海南海药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800009768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0060","BK0070","BK0188","BK0146"],"gpt_icon":0},{"id":"2481904955","title":"海南海药(000566.SZ)拟与西恩尤斯等就ECMO配套产品开展合作 加快布局高端医疗器械领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2481904955","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481904955?lang=zh_cn&edition=full","pubTime":"2024-11-07 21:07","pubTimestamp":1730984869,"startTime":"0","endTime":"0","summary":"据悉，本次签署《初始合资合同》体现海南海药、海口国科、西恩尤斯三方对未来有明确的合作意向，将有助于与财务投资人进一步洽谈及员工持股平台进一步规划。若本次合作顺利达成，将进一步推进海南海药加快布局高端医疗器械领域，推动公司的持续发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK1583","BK0060","BK0146","09996","BK1222","159883","BK1574","000566","BK0070","BK0188","BK1100","BK0239"],"gpt_icon":0},{"id":"2481906309","title":"海南海药最新公告：股票交易异常波动 近期经营情况正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481906309?lang=zh_cn&edition=full","pubTime":"2024-11-07 20:31","pubTimestamp":1730982660,"startTime":"0","endTime":"0","summary":"海南海药公告，公司股票于2024年11月5日至11月7日连续3个交易日收盘价格涨幅偏离值累计达到20%以上，属于股票异常波动情况。公司关注并核实，前期披露的信息不存在需要更正、补充之处，未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信息，近期经营情况正常及内外部经营环境未发生重大变化。控股股东和实际控制人不存在关于本公司的应披露而未披露的重大事项，或处于筹划阶段的重大事项。股票异常波动期间，公司控股股东、实际控制人未买卖公司股票。公司不存在其他重大风险事项。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700033919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0188","BK0060","BK0146","000566"],"gpt_icon":0},{"id":"2481065399","title":"海南海药最新公告：与海口国科、西恩尤斯签订初始合资合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2481065399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481065399?lang=zh_cn&edition=full","pubTime":"2024-11-07 20:29","pubTimestamp":1730982598,"startTime":"0","endTime":"0","summary":"海南海药公告，公司与海口高新区国科产业控股有限公司、德国费森尤斯集团子企业Xenios AG拟就ECMO（体外膜肺氧合）配套产品开展合作，并签署《初始合资合同》。公司预计出资金额不超过人民币2亿元。本次合作将有助于与财务投资人进一步洽谈及员工持股平台进一步规划，若顺利达成，将推进公司加快布局高端医疗器械领域。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700033917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","BK0188","BK0146","BK0070","BK0060"],"gpt_icon":0},{"id":"2481905464","title":"海南海药：签署不超2亿元初始合资合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2481905464","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481905464?lang=zh_cn&edition=full","pubTime":"2024-11-07 20:29","pubTimestamp":1730982545,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0146","09997","BK1222","159883","BK1583","09996","BK0060","BK0188","BK0070","BK1574","BK1100","BK0239","000566"],"gpt_icon":0},{"id":"2481940880","title":"11月7日海南海药涨停分析：食品，民营医院，保健品概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481940880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481940880?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:20","pubTimestamp":1730964009,"startTime":"0","endTime":"0","summary":"证券之星消息，海南海药11月7日涨停收盘，收盘价6.46元。该股于10点2分涨停，2次打开涨停，截止收盘封单资金为5121.52万元，占其流通市值0.68%。11月7日的资金流向数据方面，主力资金净流入2393.82万元，占总成交额2.29%，游资资金净流出2362.16万元，占总成交额2.26%，散户资金净流出31.66万元，占总成交额0.03%。近5日资金流向一览见下表：该股为食品，民营医院，保健品概念热股，当日食品概念上涨4.94%，民营医院概念上涨4.92%，保健品概念上涨4.01%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700020145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000566","BK0239","09906","BK0188","BK0060","BK0070","BK1209","BK0146"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1994-05-25","address":"海南省海口市秀英区南海大道192号","stockEarnings":[{"period":"1week","weight":-0.0998},{"period":"1month","weight":0},{"period":"3month","weight":0.3434},{"period":"6month","weight":0.75},{"period":"1year","weight":0.1744},{"period":"ytd","weight":0.177}],"companyName":"海南海药股份有限公司","boardCode":"AI0027","perCapita":"14942股","boardName":"医药制造业","registeredCapital":"129736万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 海南海药股份有限公司主营业务是药品及医疗器械研发、生产和销售。公司的主要产品是抗生素系列、胃肠道用药系列、抗肿瘤药系列、与制剂配套的原料药和中间体系列及其他产品。公司产品枫蓼肠胃康颗粒2023年市场占有率56%，国内排名第一，头孢唑肟钠2023年市场占有率10.6%，国内排名第二，头孢西丁钠2023年市场占有率15.9,%，国内排名第二。","serverTime":1734671498621,"listedPrice":5.8,"stockholders":"78025人(较上一季度增加5.60%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海南海药,000566,海南海药股票,海南海药股票老虎,海南海药股票老虎国际,海南海药行情,海南海药股票行情,海南海药股价,海南海药股市,海南海药股票价格,海南海药股票交易,海南海药股票购买,海南海药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海南海药(000566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海南海药(000566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}